Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
09/1999
09/21/1999US5955594 Nucleic acids encoding proteins for early liver development
09/21/1999US5955593 BH3 interacting domain death agonist
09/21/1999US5955592 Nucleotide and amino acid sequences; for diagnosis of susceptiblity to cancer or diabetes
09/21/1999US5955589 Gapped 2' modified oligonucleotides
09/21/1999US5955585 Catalytic condensation method for the preparation of chlorophyll and bacteriochlorophyll derivatives
09/21/1999US5955489 Taxane derivatives, the preparation thereof and formulations containing them
09/21/1999US5955476 Substituted 2-(2,6-dioxo-3-fluoropiperidin-3-yl)-isoindolines and method of reducing inflammatory cytokine levels
09/21/1999US5955464 4-anilinoquinazoline derivatives bearing a heteroaryl substituted at the 6-position and possessing anti-cell-proliferation properties
09/21/1999US5955463 Antitumor, antiinflammatory, and antiarthritic agents
09/21/1999US5955457 Water soluble rapamycin esters
09/21/1999US5955443 Treatment and diagnosis of diseases or disorders amenable to treatment through modulation of expression of a nucleic acid encoding a platelet endothelial cell adhesion molecule-1 (pecam-1; also known as cd31 antigen or endocam) protein are
09/21/1999US5955440 Macrolide LHRH antagonists
09/21/1999US5955429 Human apoptosis-associated protein
09/21/1999US5955428 DNA encoding human metallothionein
09/21/1999US5955426 Such peptides radiolabeled with a radiosiotope, as well as methods for using such peptides for radiodiagnostic and radiotherapeutic purposes
09/21/1999US5955338 Phosphatidylinositol 4,5-bisphosphate 5-phosphatase
09/21/1999US5955314 Nucleotide sequence that codes polypeptide controller of g-protein signaling; prevention and diagnosis of cancer; anticarcinogenic agents; antiinflammatory agents; therapy of nervous system disorders; antisense agents
09/21/1999US5955313 Nucleic acid molecule encoding a bifunctional protein, the protein so encoded uses thereof
09/21/1999US5955309 Polynucleotide encoding G-protein coupled receptor (H7TBA62)
09/21/1999US5955291 Antibodies against extrcellular domain; useful as a diagnostic tool of tumor formation; monitoring of wound healing; imaging agents
09/21/1999US5955282 Human galactosyltransferases
09/21/1999US5955260 Antibodies that bind viral proteins that share homogeneity; for diagnostic immunoassay of virus in sample
09/21/1999US5955100 Prodrugs their preparation and use as pharmaceuticals
09/21/1999US5955075 Molecular hybridization, genetic engineering
09/21/1999US5955073 Selective RNase cytotoxic reagents
09/21/1999US5955059 Treating psoriasis, other skin disorders
09/21/1999CA2012867C Novel cytotoxic cyclic depsipeptides from the tunicate trididemnum solidum
09/16/1999WO1999046594A2 C-myc coding region determinant-binding protein (crd-bp)
09/16/1999WO1999046389A1 Recombinant onconase, and chemical conjugates and fusion proteins of recombinant onconase
09/16/1999WO1999046375A2 Human nucleic acid sequences from prostate tissue
09/16/1999WO1999046374A2 Human nucleic acid sequences from prostate tumour tissue
09/16/1999WO1999046289A1 31 human secreted proteins
09/16/1999WO1999046284A2 Molecules that home to various selected organs or tissues
09/16/1999WO1999046283A1 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
09/16/1999WO1999046282A1 Plasminogen-related gene b polypeptides
09/16/1999WO1999046281A2 Novel polypeptides and nucleic acids encoding the same
09/16/1999WO1999046279A2 INHIBITORS OF TYPE 5 AND TYPE 3 17β-HYDROXYSTEROID DEHYDROGENASE AND METHODS FOR THEIR USE
09/16/1999WO1999046272A1 Serine peptidase modulators
09/16/1999WO1999046268A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases)
09/16/1999WO1999046248A1 1,2-diazepane derivatives as interleukin-1beta converting enzyme inhibitors
09/16/1999WO1999046241A1 Cytostatic agents
09/16/1999WO1999046237A1 Modulators of protein tyrosine phosphatases
09/16/1999WO1999045954A1 Hla-binding peptides and their uses
09/16/1999WO1999045945A1 Improved radiation therapy methods
09/16/1999WO1999045935A1 Novel nucleoside analogs and uses in treating disease
09/16/1999WO1999045927A1 Vitronectin receptor antagonists
09/16/1999WO1999045919A1 Phenanthrofuran derivatives
09/16/1999WO1999045918A1 Methods and compositions for delivery of taxanes
09/16/1999WO1999045912A1 Monoterpenoid derivatives for treatment of cancer
09/16/1999WO1999045909A2 Use of nitrone compounds for the inhibition of angiogenesis
09/16/1999WO1999045904A1 Delivery system to modulate immune response
09/16/1999WO1999045788A1 Food products having enhanced cocoa polyphenol content and processes for producing same
09/16/1999WO1999036063A3 Vanadium (iv) metallocene complexes having spermicidal activity
09/16/1999WO1999033868A3 Human papillomavirus vaccine
09/16/1999WO1999033858A3 Estrone sulfamate inhibitors of estrone sulfatase, and associated pharmaceutical compositions and methods of use
09/16/1999WO1999032625A3 Nucleotide and protein sequence of mammastatin and methods of use
09/16/1999WO1999029878A3 Methods of producing anti-angiogenic proteins: endostatin, angiostatin or restin, using a pichia yeast expression system
09/16/1999WO1999029321A9 Inhibition of membrane-associated viral replication
09/16/1999WO1999028304A9 Pdgf receptor kinase inhibitory compounds, their preparation and compositions
09/16/1999WO1999015684A9 Expression of genes in hematopoietic stem cells in hischaemic conditions
09/16/1999WO1999015657A3 53bp2 complexes
09/16/1999DE19811194A1 New nucleic acid expressed at high level in normal prostatic tissue and encoded polypeptides, used to treat cancer and screen for therapeutic agents
09/16/1999DE19811193A1 New nucleic acid expressed at high level in prostatic tumor tissue and encoded polypeptides, useful for treating cancer and screening for therapeutic agents
09/16/1999CA2659664A1 Improved radiation therapy methods
09/16/1999CA2421394A1 Novel polypeptides and nucleic acids encoding the same
09/16/1999CA2421388A1 Novel poypeptides and nucleic acids encoding the same
09/16/1999CA2421375A1 Novel polypeptides and nucleic acids encoding the same
09/16/1999CA2421372A1 Novel polypeptides and nucleic acids encoding the same
09/16/1999CA2421364A1 Novel polypeptides and nucleic acids encoding the same
09/16/1999CA2421345A1 Novel polypeptides and nucleic acids encoding the same
09/16/1999CA2421333A1 Pro 351 polypeptides and nucleic acids encoding the same
09/16/1999CA2421329A1 Novel polypeptides and nucleic acids encoding the same
09/16/1999CA2421322A1 Pro703 polypeptides and nucleic acids encoding the same
09/16/1999CA2421319A1 Novel polypeptides and nucleic acids encoding the same
09/16/1999CA2421315A1 Novel polypeptides and nucleic acids encoding the same
09/16/1999CA2323632A1 Hla-binding peptides and their uses
09/16/1999CA2323631A1 Recombinant onconase, and chemical conjugates and fusion proteins of recombinant onconase
09/16/1999CA2323493A1 Modulators of protein tyrosine phosphatases (ptpases)
09/16/1999CA2323490A1 inhibition of angiogenesis
09/16/1999CA2323460A1 Plasminogen-related gene b polypeptides
09/16/1999CA2323208A1 Vitronectin receptor antagonists
09/16/1999CA2323089A1 Inhibitors of type 5 and type 3 17.beta.-hydroxysteroid dehydrogenase and methods for their use
09/16/1999CA2322962A1 Phenanthrofuran derivatives
09/16/1999CA2322728A1 31 human secreted proteins
09/16/1999CA2322494A1 Novel nucleoside analogs and uses in treating disease
09/16/1999CA2322472A1 Delivery system to modulate immune response
09/16/1999CA2322165A1 Monoterpenoid derivatives for treatment of cancer
09/16/1999CA2321026A1 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
09/16/1999CA2288240A1 Methods and compositions for delivery of taxanes
09/15/1999EP0941998A2 3,6-ketal and enol ether macrolide antibiotics
09/15/1999EP0941737A1 Apoptosis inducers
09/15/1999EP0941733A2 Methods of inhibiting leaderless protein export using cardiac glycosides and derivatives
09/15/1999EP0941364A1 Process aimed at evidencing the state of a malignant cell and process for treatment
09/15/1999EP0941334A2 Protease-activatable pseudomonas exotoxin a-like proproteins
09/15/1999EP0941328A1 Human breast tumor-specific proteins
09/15/1999EP0941321A1 Circularly permuted polypeptides as novel stem cell factor receptor agonists
09/15/1999EP0941317A1 Insulin-like growth factor 1 receptor (igf-1r) antisense oligonucleotide-treated breast cancer cells composition
09/15/1999EP0941313A1 Prostate-specific kallikrein
09/15/1999EP0941253A1 New butyric esters with antiproliferative activity and the pharmaceutical compositions containing them
09/15/1999EP0941247A2 Peptide compounds useful for modulating fgf receptor activity
1 ... 1950 1951 1952 1953 1954 1955 1956 1957 1958 1959 1960 1961 1962 1963 1964 1965 1966 1967 1968 1969 1970 ... 2211